Previously treated cases tested for RR-/MDR-TB (%) in India
India: Previously treated cases tested for RR-/MDR-TB was 86.0% in 2024. ◆ Volatile
Previously treated cases tested for RR-/MDR-TB in India, 2007–2024
Source: World Health Organization, Global Health Observatory.
Analysis
India recorded 86.0% for previously treated cases tested for rr-/mdr-tb in 2024.
That represents a change of up 24.6% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in India peaked at 96.0% in 2020 and was at its lowest, 0.1%, in 2007.
India ranks 97th of 180 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Previously treated cases tested for RR-/MDR-TB in India, year by year
| Year | Value | Change |
|---|---|---|
| 2007 | 0.1% | — |
| 2008 | 0.5% | +246.7% |
| 2009 | 1.2% | +130.8% |
| 2014 | 69.0% | +5650.0% |
| 2015 | 60.0% | -13.0% |
| 2016 | 69.0% | +15.0% |
| 2017 | 88.0% | +27.5% |
| 2018 | 65.0% | -26.1% |
| 2019 | 82.0% | +26.2% |
| 2020 | 96.0% | +17.1% |
| 2021 | 73.0% | -24.0% |
| 2022 | 80.0% | +9.6% |
| 2023 | 86.0% | +7.5% |
| 2024 | 86.0% | +0.0% |
India compared with similar countries
- India's 86.0% is below the median for lower middle income countries, which is 90.0%, 96% of the median. (47 countries reporting)
- India's 86.0% is below the median for South Asia, which is 93.0%, 92% of the median. (6 countries reporting)
Biggest year-on-year movements
Years where Previously treated cases tested for RR-/MDR-TB in India changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2014 | +5650.0% | 1.2% | 69.0% |
| 2008 | +246.7% | 0.1% | 0.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.6% | 0.1% | 1.2% | 3 |
| 2010s | 72.2% | 60.0% | 88.0% | 6 |
| 2020s | 84.2% | 73.0% | 96.0% | 5 |
Countries ranked near India
- 97 Uzbekistan 86.0% compare
- 97 Turkey 86.0% compare
- 100 Mexico 85.0% compare
- 100 Democratic Republic of Congo 85.0% compare
- 100 Guatemala 85.0% compare
More health data for India
- Un projection of annual infant deaths, annual growth rate -2.12 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4372 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,332 deaths per 1,000 people (2090)
- Number of infants who die before age 1 44,822 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 38 (2025)
- Population ages 00-04, female, annual growth rate -0.3809 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0372 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.5922 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in India?
- Previously treated cases tested for rr-/mdr-tb in India was 86.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in India?
- The highest recorded value was 96.0% in 2020.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in India?
- The lowest recorded value was 0.1% in 2007.
- How does India rank for previously treated cases tested for rr-/mdr-tb?
- India ranks 97th out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in India?
- Over the last ten years it is up 24.6%. The long-run trend across the full record is volatile.
- Where does this India data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 14 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).